Fresenius Medical Care plans to buy NxStage Medical for about $2 billion
MLex Summary: Fresenius Medical Care plans to acquire rival dialysis provider NxStage Medical in a deal worth approximately $2 billion in cash, Fresenius Medical Care said in a statement. The addition...To view the full article, register now.
Already a subscriber? Click here to view full article